Surgical management of advanced or recurrent endometrial cancer

Surgical Clinics of North America

Volumn 81, Issue 4, 2001, Pages 885-896

  Chi, Dennis S ^b   Barakat, Richard R ^b  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADVANCED CANCER; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; ENDOMETRIUM CANCER; FEMALE; HUMAN; PRIORITY JOURNAL; PROGNOSIS; RECURRENT CANCER; REVIEW; SALVAGE THERAPY; TUMOR VOLUME;

EID: 0035206145     PISSN: 00396109     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0039-6109(05)70172-9     Document Type: Article

References (53)

1. Clinical (stage III) as compared to subclinical intrapelvic extrauterine tumor spread in endometrial carcinoma: A clinical and histopathological study of 175 patients
2. Recurrent adenocarcinoma of the endomtrium: A clinical and histopathological study of 379 patients
3. Endometrial carcinoma: Relative effectiveness of adjuvant irradiation vs. therapy reserved for relapse
4. A phase II trial of paclitaxel in patients with advanced or recurrent adenocarcinoma of the endometrium: A Gynecologic Oncology Group study
5. Pelvic exenteration for recurrent endometrial cancer
6. Corpus: Epithelial tumors
7. Relative prognostic significance of preoperative and operative findings in pelvic exenteration
8. Surgical staging in endometrial cancer: Clinical-pathologic findings of a prospective study
9. Stage IVB endometrial carcinoma: The role of cytoreductive surgery and determinants of survival
10. Stage III adenocarcinoma of the endometrium: Two prognostic groups
11. Complete excision of pelvic viscera for advanced carcinoma: A one-stage abdominoperineal operation with end colostomy and bilateral ureteral implantation into the colon above the colostomy
12. Treatment failure in endometrial carcinoma
13. Surgery for malignant tumors of the uterine corpus
14. Long-term experience in the surgical management of cancer of the uterine cervix
15. The role of surgical cytoreduction in stage IV endometrial carcinoma
16. The significance of adnexal involvement in endometrial carcinoma
17. Endometrial cancer with para-aortic adenopathy: Patterns of failure and opportunities for cure
18. Carcinoma of the corpus uteri
19. Surgical pathologic spread patterns of endometrial cancer: A Gynecologic Oncology Group study
20. Stage III endometrial carcinoma: Analysis of patterns of failure and therapeutic implications
21. The role of intraoperative radiation therapy (IORT) in the treatment of locally advanced gynecologic malignancies
22. Risk factors and recurrent patterns in stage I endometrial cancer
23. Classification and staging of malignant tumors in the female pelvis
24. Corpus cancer staging
25. Intraoperative radiation therapy in gynecologic cancer: The Mayo Clinic experience
26. Radical surgical resection and high dose intra-operative therapy (HDR-IORT) in patients with recurrent gyncecologic cancers
27. Stage III carcinoma of the endometrium: A review of 41 cases
28. Surgical stage IV endometrial carcinoma: A study of 47 cases
29. Cancer statistics, 2000
30. Treatment of intraperitoneal metastatic adenocarcinoma of the endometrium by the whole-abdomen moving strip technique and pelvic boost irradiation
31. Pathological risk factors and outcomes for isolated adnexal metastases in endometrial cancer
32. IORT for locally advanced gynecologic malignancies
33. Adenocarcinoma of the endometrium: Survival comparisons of patients with and without pelvic node sampling
34. Results of radiotherapy in recurrent endometrial carcinoma: A retrospective analysis of 51 patients
35. Surgery without radiotherapy for primary treatment of endometrial cancer
36. Stage III endometrial carcinoma
37. Potential therapeutic role of para-aortic lymphadenectomy in node-positive endometrial cancer
38. Treatment of recurrent adenocarcinoma of the endometrium with pelvic exenteration
39. Relationship between surgical-pathologic risk factors and outcome in clinical stage I and II carcinoma of the endometrium: A Gynecologic Oncology Group study
40. FIGO stage IIIC endometrial carcinoma with metastases confined to pelvic lymph nodes: Analysis of treatment outcomes, prognostic variables, and failure patterns following adjuvant radiation therapy
41. Treatment of node-positive endometrial cancer with complete node dissection, chemotherapy, and radiation therapy
42. Para-aortic lymph node radiotherapy in cancer of the uterine corpus
43. Radiation therapy and combined chemo-irradiation in advanced and recurrent endometrial carcinoma
44. Whole abdominal radiotherapy versus combination chemotherapy with doxorubicin and cisplatin in advancced endometrial carcinoma (phase III): Gynecologic Oncology Study No. 122
45. Surveillance for recurrent endometrial carcinoma: Development of a follow-up scheme
46. A phase III randomized study of surgery vs surgery plus adjunctive radiation therapy in intermediate-risk endometrial adenocarcinoma (GOG No 99)
47. Radiation therapy for surgically proven para-aortic node metastasis in endometrial carcinoma
48. Practice guidelines: Uterine corpus-endometrial cancer
49. Phase III trial of doxorubicin +/- cisplatin in advanced or recurrent endometrial carcinoma: A Gynecologic Oncology Group (GOG) study
50. Phase II trial of cisplatin as first-line chemotherapy in patients with advanced or recurrent endometrial carcinoma: A Gynecologic Oncology Group study
51. Phase II trial of Adriamycin in the treatment of advanced or recurrent endometrial carcinoma: A Gynecologic Oncology Group study
52. Staging laparotomy in early ovarian cancer
53. Endometrial carcinoma: Causes of death and sites of treatment failure